Integrating proteomic and metabolomic data obtained from mAITL lymphoma CD4 + PD1high T cells and wild-type (WT) CD4 + cells, allowed us to identify a specific lipid metabolic pathway involved. This evidence concerns the gene CD4 and lymphoma.